MongoDB, Inc. (NASDAQ: MDB) Stock Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
01/04/2024 | 11.9% | UBS | $475 → $410 | Downgrades | Buy → Neutral |
12/06/2023 | 14.63% | Mizuho | $330 → $420 | Maintains | Neutral |
12/06/2023 | 29.64% | RBC Capital | $445 → $475 | Maintains | Outperform |
12/06/2023 | 30.46% | Barclays | $470 → $478 | Maintains | Overweight |
12/06/2023 | 35.1% | Needham | $445 → $495 | Maintains | Buy |
12/06/2023 | 36.46% | Piper Sandler | $425 → $500 | Maintains | Overweight |
12/04/2023 | 22.82% | Stifel | → $450 | Reiterates | Buy → Buy |
11/16/2023 | 36.46% | Wells Fargo | → $500 | Initiates Coverage On | → Overweight |
11/13/2023 | 17.36% | Truist Securities | → $430 | Reiterates | Buy → Buy |
11/08/2023 | 16.54% | Capital One | → $427 | Upgrades | Equal-Weight → Overweight |
10/23/2023 | 20.09% | Keybanc | $495 → $440 | Maintains | Overweight |
10/12/2023 | 22.82% | B of A Securities | → $450 | Initiates Coverage On | → Buy |
10/10/2023 | -8.57% | Scotiabank | → $335 | Initiates Coverage On | → Sector Perform |
10/06/2023 | 35.1% | Tigress Financial | $490 → $495 | Reiterates | Buy → Buy |
09/05/2023 | 22.82% | Canaccord Genuity | $410 → $450 | Maintains | Buy |
09/05/2023 | 32.1% | Argus Research | $435 → $484 | Maintains | Buy |
09/01/2023 | 26.91% | UBS | $425 → $465 | Maintains | Buy |
09/01/2023 | 17.36% | Truist Securities | $420 → $430 | Maintains | Buy |
09/01/2023 | 31% | Morgan Stanley | $440 → $480 | Maintains | Overweight |
09/01/2023 | 21.45% | RBC Capital | → $445 | Reiterates | Outperform → Outperform |
09/01/2023 | 22.82% | Barclays | $421 → $450 | Maintains | Overweight |
09/01/2023 | -31.77% | Guggenheim | $220 → $250 | Maintains | Sell |
09/01/2023 | 22.82% | Stifel | $420 → $450 | Maintains | Buy |
09/01/2023 | 31% | Oppenheimer | $430 → $480 | Maintains | Outperform |
09/01/2023 | 20.09% | JMP Securities | $425 → $440 | Maintains | Market Outperform |
09/01/2023 | 21.45% | Needham | $430 → $445 | Maintains | Buy |
09/01/2023 | 15.99% | Piper Sandler | $400 → $425 | Maintains | Overweight |
08/28/2023 | 24.18% | Citigroup | $430 → $455 | Maintains | Buy |
07/24/2023 | 15.99% | JMP Securities | $400 → $425 | Maintains | Outperform |
07/21/2023 | 26.09% | Keybanc | $372 → $462 | Maintains | Overweight |
06/28/2023 | 33.73% | Tigress Financial | $365 → $490 | Maintains | Buy |
06/26/2023 | 14.9% | Barclays | $374 → $421 | Maintains | Overweight |
06/26/2023 | 8.08% | Capital One | → $396 | Initiates Coverage On | → Equal-Weight |
06/23/2023 | 14.63% | Truist Securities | $365 → $420 | Maintains | Buy |
06/23/2023 | 20.09% | Morgan Stanley | $270 → $440 | Maintains | Overweight |
06/23/2023 | 21.45% | RBC Capital | $400 → $445 | Maintains | Outperform |
06/23/2023 | 11.9% | Wedbush | → $410 | Reiterates | Outperform → Outperform |
06/23/2023 | 17.36% | Needham | → $430 | Reiterates | Buy → Buy |
06/23/2023 | 9.17% | Piper Sandler | → $400 | Reiterates | Overweight → Overweight |
06/06/2023 | 11.9% | Canaccord Genuity | $250 → $410 | Maintains | Buy |
06/05/2023 | 14.63% | Goldman Sachs | $280 → $420 | Maintains | Buy |
06/05/2023 | 15.72% | Bernstein | $257 → $424 | Maintains | Outperform |
06/02/2023 | 9.17% | RBC Capital | $235 → $400 | Maintains | Outperform |
06/02/2023 | 2.35% | Stifel | $240 → $375 | Maintains | Buy |
06/02/2023 | -0.38% | Truist Securities | $235 → $365 | Maintains | Buy |
06/02/2023 | -39.96% | Mizuho | $180 → $220 | Maintains | Neutral |
06/02/2023 | 17.36% | Oppenheimer | $270 → $430 | Maintains | Outperform |
06/02/2023 | 17.36% | Needham | $250 → $430 | Maintains | Buy |
06/02/2023 | 6.44% | Baird | $290 → $390 | Maintains | Outperform |
06/02/2023 | 17.36% | Citigroup | $363 → $430 | Maintains | Buy |
06/02/2023 | 2.07% | Barclays | $280 → $374 | Maintains | Overweight |
06/02/2023 | 0.98% | JMP Securities | $245 → $370 | Maintains | Market Outperform |
06/02/2023 | 14.63% | Goldman Sachs | $280 → $420 | Maintains | Buy |
06/02/2023 | 9.17% | Piper Sandler | $270 → $400 | Maintains | Overweight |
05/31/2023 | -20.85% | Baird | $230 → $290 | Maintains | Outperform |
05/26/2023 | -42.69% | Guggenheim | $205 → $210 | Downgrades | Neutral → Sell |
05/19/2023 | -0.93% | Citigroup | $290 → $363 | Maintains | Buy |
05/15/2023 | -23.58% | Barclays | $257 → $280 | Maintains | Overweight |
04/20/2023 | -0.38% | Tigress Financial | → $365 | Reiterates | → Buy |
04/20/2023 | -27.95% | Keybanc | $229 → $264 | Maintains | Overweight |
04/12/2023 | -26.31% | Morgan Stanley | $230 → $270 | Upgrades | Equal-Weight → Overweight |
03/10/2023 | -31.77% | Credit Suisse | $305 → $250 | Maintains | Outperform |
03/09/2023 | -37.23% | Baird | → $230 | Maintains | Outperform |
03/09/2023 | -35.86% | RBC Capital | → $235 | Reiterates | → Outperform |
03/09/2023 | -23.58% | Goldman Sachs | $325 → $280 | Maintains | Buy |
03/09/2023 | -31.77% | Needham | $240 → $250 | Maintains | Buy |
03/09/2023 | -50.87% | Mizuho | $220 → $180 | Maintains | Neutral |
03/09/2023 | -20.85% | Citigroup | $295 → $290 | Maintains | Buy |
03/09/2023 | -26.31% | Oppenheimer | $320 → $270 | Maintains | Outperform |
03/09/2023 | -33.13% | JMP Securities | $215 → $245 | Maintains | Market Outperform |
03/09/2023 | -29.86% | Barclays | $264 → $257 | Maintains | Overweight |
03/09/2023 | -26.31% | Piper Sandler | → $270 | Reiterates | → Overweight |
03/07/2023 | -19.49% | Citigroup | $300 → $295 | Maintains | Buy |
02/22/2023 | -34.5% | Stifel | $256 → $240 | Maintains | Buy |
02/17/2023 | -23.03% | Bernstein | → $282 | Initiates Coverage On | → Outperform |
02/15/2023 | -27.95% | Barclays | $240 → $264 | Maintains | Overweight |
02/15/2023 | -39.96% | Mizuho | $170 → $220 | Maintains | Neutral |
02/06/2023 | -30.4% | Keybanc | $220 → $255 | Maintains | Overweight |
01/27/2023 | -44.05% | Guggenheim | → $205 | Initiates Coverage On | → Neutral |
01/08/2023 | -35.86% | Truist Securities | $300 → $235 | Maintains | Buy |
12/21/2022 | -34.5% | Needham | $225 → $240 | Maintains | Buy |
12/15/2022 | -0.38% | Tigress Financial | $575 → $365 | Maintains | Buy |
12/15/2022 | -34.5% | Wedbush | → $240 | Initiates Coverage On | → Outperform |
12/07/2022 | -30.13% | Stifel | $320 → $256 | Maintains | Buy |
12/07/2022 | -12.66% | Oppenheimer | $375 → $320 | Maintains | Outperform |
12/07/2022 | -37.23% | Morgan Stanley | $215 → $230 | Maintains | Equal-Weight |
12/07/2022 | -11.3% | Goldman Sachs | $380 → $325 | Maintains | Buy |
12/07/2022 | -34.5% | Barclays | $233 → $240 | Maintains | Overweight |
12/07/2022 | -16.76% | Credit Suisse | $400 → $305 | Maintains | Outperform |
12/07/2022 | -53.6% | Mizuho | $190 → $170 | Maintains | Neutral |
12/07/2022 | -41.32% | UBS | $200 → $215 | Maintains | Buy |
12/07/2022 | -41.32% | JMP Securities | → $215 | Upgrades | Market Perform → Market Outperform |
12/07/2022 | -38.59% | Needham | $330 → $225 | Maintains | Buy |
12/05/2022 | -44.05% | Baird | $330 → $205 | Maintains | Outperform |
11/29/2022 | -45.41% | UBS | $390 → $200 | Maintains | Buy |
11/28/2022 | -19.49% | Citigroup | $445 → $295 | Maintains | Buy |
11/21/2022 | -41.32% | Keybanc | → $215 | Initiates Coverage On | → Overweight |
11/21/2022 | -41.32% | Morgan Stanley | $368 → $215 | Downgrades | Overweight → Equal-Weight |
11/18/2022 | -36.41% | Barclays | $300 → $233 | Maintains | Overweight |
11/15/2022 | -48.14% | Mizuho | $300 → $190 | Maintains | Neutral |
10/20/2022 | -26.31% | Piper Sandler | $350 → $270 | Maintains | Overweight |
10/18/2022 | — | Redburn Partners | Upgrades | Sell → Neutral | |
10/18/2022 | -18.12% | Barclays | $360 → $300 | Maintains | Overweight |
09/30/2022 | -18.12% | Truist Securities | → $300 | Initiates Coverage On | → Buy |
09/01/2022 | -12.66% | Stifel | $340 → $320 | Maintains | Buy |
09/01/2022 | -1.75% | Canaccord Genuity | $300 → $360 | Maintains | Buy |
09/01/2022 | -9.93% | Baird | $360 → $330 | Maintains | Outperform |
09/01/2022 | 6.44% | UBS | $430 → $390 | Maintains | Buy |
09/01/2022 | 9.17% | Credit Suisse | $500 → $400 | Maintains | Outperform |
09/01/2022 | -9.93% | Needham | $350 → $330 | Maintains | Buy |
09/01/2022 | -4.48% | RBC Capital | $400 → $350 | Maintains | Outperform |
09/01/2022 | 21.45% | Citigroup | $450 → $445 | Maintains | Buy |
09/01/2022 | -1.75% | Barclays | $438 → $360 | Maintains | Overweight |
09/01/2022 | -4.48% | Piper Sandler | $375 → $350 | Maintains | Overweight |
08/22/2022 | 22.82% | Citigroup | $425 → $450 | Maintains | Buy |
08/17/2022 | 6.44% | Mizuho | $270 → $390 | Maintains | Buy |
08/16/2022 | 19.54% | Barclays | $338 → $438 | Maintains | Overweight |
07/18/2022 | 2.35% | Piper Sandler | $430 → $375 | Maintains | Overweight |
07/13/2022 | -1.75% | Baird | → $360 | Initiates Coverage On | → Outperform |
06/29/2022 | -48.14% | Redburn Partners | → $190 | Initiates Coverage On | → Sell |
06/10/2022 | -4.48% | Needham | $310 → $350 | Maintains | Buy |
06/09/2022 | 2.35% | RBC Capital | $325 → $375 | Maintains | Outperform |
06/08/2022 | -5.84% | UBS | $315 → $345 | Maintains | Buy |
06/02/2022 | 15.99% | Citigroup | $405 → $425 | Maintains | Buy |
06/02/2022 | -7.21% | Stifel | $425 → $340 | Maintains | Buy |
06/02/2022 | -18.12% | Canaccord Genuity | $400 → $300 | Maintains | Buy |
06/02/2022 | 0.44% | Morgan Stanley | $378 → $368 | Maintains | Overweight |
06/02/2022 | 36.46% | Credit Suisse | $650 → $500 | Maintains | Outperform |
06/02/2022 | 9.17% | Oppenheimer | $490 → $400 | Maintains | Outperform |
06/02/2022 | -7.75% | Barclays | $330 → $338 | Maintains | Overweight |
06/02/2022 | -15.39% | Needham | $362 → $310 | Maintains | Buy |
06/02/2022 | 17.36% | Piper Sandler | $585 → $430 | Maintains | Overweight |
06/01/2022 | 10.53% | Citigroup | $525 → $405 | Maintains | Buy |
05/20/2022 | -9.93% | Barclays | $410 → $330 | Maintains | Overweight |
05/19/2022 | 3.17% | Morgan Stanley | $475 → $378 | Maintains | Overweight |
05/18/2022 | -26.31% | Mizuho | $325 → $270 | Maintains | Neutral |
03/18/2022 | 22.82% | UBS | $345 → $450 | Upgrades | Neutral → Buy |
03/16/2022 | 29.64% | Morgan Stanley | $633 → $475 | Maintains | Overweight |
03/09/2022 | 15.99% | Stifel | $550 → $425 | Maintains | Buy |
03/09/2022 | -1.2% | Needham | $626 → $362 | Maintains | Buy |
03/09/2022 | -11.3% | Mizuho | $400 → $325 | Maintains | Neutral |
03/09/2022 | 11.9% | Barclays | $556 → $410 | Maintains | Overweight |
03/09/2022 | 77.4% | Credit Suisse | $700 → $650 | Maintains | Outperform |
03/01/2022 | 37.83% | RBC Capital | → $505 | Initiates Coverage On | → Outperform |
02/15/2022 | 9.17% | Mizuho | $490 → $400 | Maintains | Neutral |
02/11/2022 | 71.94% | Tigress Financial | → $630 | Initiates Coverage On | → Buy |
12/16/2021 | 72.76% | Morgan Stanley | $525 → $633 | Maintains | Overweight |
12/08/2021 | 48.74% | Goldman Sachs | $475 → $545 | Maintains | Buy |
12/07/2021 | 50.11% | Stifel | $495 → $550 | Maintains | Buy |
12/07/2021 | 52.84% | Canaccord Genuity | $475 → $560 | Maintains | Buy |
12/07/2021 | 43.29% | Morgan Stanley | $480 → $525 | Maintains | Overweight |
12/07/2021 | 80.13% | Citigroup | $526 → $660 | Maintains | Buy |
12/07/2021 | 33.73% | Mizuho | $475 → $490 | Maintains | Neutral |
12/07/2021 | 70.85% | Needham | $534 → $626 | Maintains | Buy |
12/07/2021 | 59.66% | Piper Sandler | $525 → $585 | Maintains | Overweight |
11/16/2021 | 91.05% | Credit Suisse | → $700 | Initiates Coverage On | → Outperform |
09/17/2021 | 61.03% | Barclays | $505 → $590 | Maintains | Overweight |
09/07/2021 | 50.11% | Argus Research | $406 → $550 | Maintains | Buy |
09/03/2021 | 35.1% | Stifel | $384 → $495 | Maintains | Buy |
09/03/2021 | 22.82% | UBS | $300 → $450 | Maintains | Neutral |
09/03/2021 | 31% | Morgan Stanley | $410 → $480 | Maintains | Overweight |
09/03/2021 | 28.28% | Oppenheimer | $400 → $470 | Maintains | Outperform |
09/03/2021 | 45.74% | Needham | $415 → $534 | Maintains | Buy |
09/03/2021 | 11.9% | Mizuho | $350 → $410 | Maintains | Neutral |
09/03/2021 | 37.83% | Barclays | $420 → $505 | Maintains | Overweight |
09/03/2021 | 43.29% | Piper Sandler | $425 → $525 | Maintains | Overweight |
08/24/2021 | 11.9% | Morgan Stanley | $377 → $410 | Maintains | Overweight |
08/23/2021 | 14.63% | Barclays | $390 → $420 | Maintains | Overweight |
07/14/2021 | 7.81% | Canaccord Genuity | $375 → $395 | Maintains | Buy |
07/14/2021 | -12.66% | Mizuho | $300 → $320 | Maintains | Neutral |
06/04/2021 | 22.82% | Citigroup | $445 → $450 | Maintains | Buy |
06/04/2021 | -18.12% | UBS | $325 → $300 | Maintains | Neutral |
06/04/2021 | -18.12% | Mizuho | $265 → $300 | Maintains | Neutral |
06/04/2021 | 13.26% | Needham | $409 → $415 | Maintains | Buy |
05/25/2021 | 2.89% | Morgan Stanley | $415 → $377 | Maintains | Overweight |
05/14/2021 | -15.39% | Goldman Sachs | → $310 | Initiates Coverage On | → Buy |
04/13/2021 | -12.66% | Mizuho | → $320 | Initiates Coverage On | → Neutral |
03/23/2021 | -11.3% | UBS | → $325 | Initiates Coverage On | → Neutral |
03/12/2021 | 10.81% | Argus Research | → $406 | Upgrades | Hold → Buy |
03/10/2021 | -18.12% | DA Davidson | $275 → $300 | Maintains | Neutral |
03/10/2021 | 13.26% | Morgan Stanley | $439 → $415 | Maintains | Overweight |
03/10/2021 | 2.35% | Canaccord Genuity | $430 → $375 | Maintains | Buy |
03/10/2021 | 11.63% | Needham | $394 → $409 | Maintains | Buy |
02/23/2021 | 36.46% | Citigroup | $465 → $500 | Maintains | Buy |
01/19/2021 | 7.53% | Needham | $341 → $394 | Maintains | Buy |
12/21/2020 | 4.8% | Stifel | $320 → $384 | Maintains | Buy |
12/17/2020 | 19.81% | Morgan Stanley | $295 → $439 | Upgrades | Equal-Weight → Overweight |
12/09/2020 | -14.03% | Canaccord Genuity | $290 → $315 | Maintains | Buy |
12/09/2020 | -6.93% | Needham | $290 → $341 | Maintains | Buy |
12/09/2020 | -10.48% | Piper Sandler | $310 → $328 | Maintains | Overweight |
12/07/2020 | -19.49% | Morgan Stanley | $270 → $295 | Maintains | Equal-Weight |
09/03/2020 | -21.67% | Barclays | $280 → $287 | Maintains | Overweight |
09/03/2020 | -12.66% | Stifel | $225 → $320 | Maintains | Buy |
09/03/2020 | -33.13% | Goldman Sachs | $215 → $245 | Maintains | Neutral |
09/03/2020 | -20.85% | Canaccord Genuity | $245 → $290 | Maintains | Buy |
09/03/2020 | -26.31% | Morgan Stanley | $205 → $270 | Maintains | Equal-Weight |
09/03/2020 | -24.95% | Oppenheimer | $240 → $275 | Maintains | Outperform |
09/03/2020 | -20.85% | Needham | $259 → $290 | Maintains | Buy |
09/03/2020 | -15.39% | Piper Sandler | $226 → $310 | Maintains | Overweight |
06/11/2020 | -44.05% | Morgan Stanley | $203 → $205 | Maintains | Equal-Weight |
06/05/2020 | -38.32% | Piper Sandler | $138 → $226 | Maintains | Overweight |
06/05/2020 | -29.31% | Needham | $253 → $259 | Maintains | Buy |
06/02/2020 | -30.95% | Needham | $170 → $253 | Maintains | Buy |
06/01/2020 | -44.6% | Morgan Stanley | $141 → $203 | Maintains | Equal-Weight |
05/28/2020 | -24.95% | Citigroup | $175 → $275 | Maintains | Buy |
05/22/2020 | -38.59% | Stifel | $160 → $225 | Maintains | Buy |
04/27/2020 | -53.6% | Needham | $172 → $170 | Maintains | Buy |
04/20/2020 | -56.33% | Stifel | $135 → $160 | Maintains | Buy |
03/18/2020 | -53.06% | Needham | $189 → $172 | Maintains | Buy |
03/18/2020 | -63.16% | Stifel | $185 → $135 | Maintains | Buy |
03/18/2020 | -52.24% | Citigroup | $200 → $175 | Maintains | Buy |
01/13/2020 | -53.33% | Morgan Stanley | $160 → $171 | Maintains | Equal-Weight |
01/06/2020 | — | Argus Research | Initiates Coverage On | → Hold | |
12/10/2019 | -54.97% | Canaccord Genuity | $185 → $165 | Maintains | Buy |
12/10/2019 | -56.33% | Morgan Stanley | $150 → $160 | Maintains | Equal-Weight |
12/10/2019 | -78.71% | Nomura | $76 → $78 | Maintains | Reduce |
10/29/2019 | -56.88% | Piper Sandler | → $158 | Initiates Coverage On | → Overweight |
10/16/2019 | -59.06% | Morgan Stanley | $160 → $150 | Maintains | Equal-Weight |
10/11/2019 | -57.7% | Oppenheimer | $180 → $155 | Maintains | Outperform |
09/05/2019 | -56.33% | Morgan Stanley | $156 → $160 | Maintains | Equal-Weight |
09/05/2019 | -49.51% | Stifel | $180 → $185 | Maintains | Buy |
09/05/2019 | -46.78% | Citigroup | $184 → $195 | Maintains | Buy |
09/05/2019 | -46.78% | Citigroup | $184 → $195 | Maintains | Buy |
09/05/2019 | -51.15% | Barclays | $178 → $179 | Maintains | Overweight |
08/27/2019 | -49.78% | Citigroup | $162 → $184 | Upgrades | Neutral → Buy |
08/13/2019 | -57.7% | Compass Point | → $155 | Initiates Coverage On | → Neutral |
06/19/2019 | -49.51% | Canaccord Genuity | $160 → $185 | Maintains | Buy |
06/19/2019 | -50.87% | Stifel | $155 → $180 | Maintains | Buy |
06/19/2019 | -48.69% | Keybanc | $165 → $188 | Maintains | Overweight |
06/06/2019 | -56.33% | Canaccord Genuity | $125 → $160 | Maintains | Buy |
06/06/2019 | -79.26% | Nomura | $70 → $76 | Maintains | Reduce |
06/06/2019 | -54.97% | Keybanc | $150 → $165 | Maintains | Overweight |
05/23/2019 | -58.24% | Morgan Stanley | $124 → $153 | Maintains | Equal-Weight |
05/15/2019 | -51.42% | Barclays | $143 → $178 | Maintains | Overweight |
03/14/2019 | -68.34% | Citigroup | $94 → $116 | Maintains | Neutral |
03/14/2019 | -65.88% | Canaccord Genuity | $95 → $125 | Maintains | Buy |
03/14/2019 | -59.06% | Keybanc | $100 → $150 | Maintains | Overweight |